Mylan’s board heads to chopping block after advisors bless shareholder revolt

Enlarge / Heather Bresch, chief executive officer of drugmaker Mylan, faces backlash and an ouster from shareholders. (credit: Getty | Bloomberg) An influential advisory firm, the Institutional Shareholder Services (ISS), has urged Mylan’s already mutinous shareholders to vote against the company’s incumbent board of directors following the damaging EpiPen scandal and exorbitant executive salaries, Reuters […]

Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M

Enlarge / Robert J. Coury of Mylan (L) and Mylan CEO Heather Bresch attend a benefit in New York City on November 2, 2015. (credit: Getty | Gilbert Carrasquillo) Last year, furor over the skyrocketing price of Mylan’s life-saving EpiPens hit a fever pitch. Lawmakers seethed, parents broke into tears at pharmacy counters, regulators opened […]

Lawsuit: Mylan’s epic EpiPen price hike wasn’t about greed—it’s worse

Enlarge / Mylan Inc. CEO Heather Bresch testifies on Capitol Hill in a hearing on “Reviewing the Rising Price of EpiPens.” (credit: Getty | Alex Wong) When Mylan dramatically increased the price of its life-saving EpiPen devices, it drew sharp rebuke all around for what seemed like a purely greedy—and heartless—move. But according to a […]